Zobrazeno 1 - 10
of 10 780
pro vyhledávání: '"Revicki, DA"'
Autor:
King MT; School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia. madeleine.king@sydney.edu.au., Revicki DA; Revicki Outcomes Research Consulting, Sarasota, FL, USA., Norman R; School of Population Health, Curtin University, Perth, WA, Australia., Müller F; Medical Psychology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands., Viney RC; Centre for Health Economics Research & Evaluation, Faculty of Health, University of Technology Sydney, Sydney, NSW, Australia., Pickard AS; Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Cella D; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Shaw JW; Patient-Reported Outcomes Assessment, Global Health Economics and Outcomes Research, Bristol Myers Squibb, Lawrenceville, NJ, USA.
Publikováno v:
PharmacoEconomics - open [Pharmacoecon Open] 2024 Jan; Vol. 8 (1), pp. 49-63. Date of Electronic Publication: 2023 Dec 07.
Publikováno v:
Patient Preference and Adherence, Vol Volume 12, Pp 35-44 (2017)
Daisy Ng-Mak,1 Jiat-Ling Poon,2 Laurie Roberts,2 Leah Kleinman,2 Dennis A Revicki,2 Krithika Rajagopalan1 1Global Health Economics and Outcomes Research, Sunovion Pharmaceuticals Inc., Marlborough, MA, 2Patient-Centered Research, Evidera, Bethesda, M
Externí odkaz:
https://doaj.org/article/2279fe5bd6e640359988f055ea1b1b9f
Autor:
Tomlinson B; Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio. Electronic address: Benjamin.Tomlinson@UHhospitals.org., de Lima M; Department of Hematology, Ohio State University, Columbus, Ohio., Cogle CR; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida., Thompson MA; Aurora Research Institute, Advocate Aurora Health, Milwaukee, Wisconsin., Grinblatt DL; NorthShore Medical Group, NorthShore University Health System, Evanston, Illinois., Pollyea DA; University of Colorado Cancer Center, Aurora, Colorado., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida., Roboz GJ; Weill Cornell College of Medicine and New York-Presbyterian Hospital, New York, New York., Savona MR; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Abedi M; University of California Davis, Comprehensive Cancer Center, Sacramento, California., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas., Kurtin SE; University of Arizona Cancer Center, Tucson, Arizona., Maciejewski JP; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Patel JL; Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, Utah., Revicki DA; Outcomes Research Consulting, Sarasota, Florida., George TI; Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, Utah., Flick ED; Bristol Myers Squibb, Princeton, New Jersey., Kiselev P; Bristol Myers Squibb, Princeton, New Jersey., Louis CU; Bristol Myers Squibb, Princeton, New Jersey., DeGutis IS; Bristol Myers Squibb, Princeton, New Jersey., Nifenecker M; Bristol Myers Squibb, Princeton, New Jersey., Erba HP; Duke Cancer Institute, North Carolina., Steensma DP; Dana-Farber Cancer Institute, Boston, Massachusetts., Scott BL; Fred Hutchinson Cancer Research Center, Seattle, Washington.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Jul; Vol. 29 (7), pp. 460.e1-460.e9. Date of Electronic Publication: 2023 Apr 21.
Autor:
Matza LS, Phillips GA, Revicki DA, Ascher-Svanum H, Malley KG, Palsgrove AC, Faries DE, Stauffer V, Kinon BJ, Awad AG, Keefe RS, Naber D
Publikováno v:
Patient Preference and Adherence, Vol 2012, Iss default, Pp 521-532 (2012)
Louis S Matza,1 Glenn A Phillips,2 Dennis A Revicki,1 Haya Ascher-Svanum,3 Karen G Malley,4 Andrew C Palsgrove,1 Douglas E Faries,3 Virginia Stauffer,3 Bruce J Kinon,3 A George Awad,5 Richard SE Keefe,6 Dieter Naber71Outcomes Research, United BioSour
Externí odkaz:
https://doaj.org/article/2e308b2fb00f4386afb38c6fcf19255b
Autor:
Zhu Y; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA., Jean-Baptiste M; Evidera Inc., Bethesda, Maryland, USA., Lenderking WR; Evidera Inc., Bethesda, Maryland, USA.; Evidera Inc., Waltham, Massachusetts, USA., Bell JA; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA., Revicki DA; Evidera Inc., Bethesda, Maryland, USA., Lin HM; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA., Brake R; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA., Reeve BB; Duke University School of Medicine, Durham, North Carolina, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (5), pp. 5494-5505. Date of Electronic Publication: 2022 Dec 30.
Autor:
Lipton RB; Albert Einstein College of Medicine, Bronx, NY, USA., Singh RBH; Mayo Clinic, Phoenix, AZ, USA., Revicki DA; Outcomes Research Consulting, Sarasota, FL, USA., Zhao S; AbbVie, Madison, NJ, USA., Shewale AR; AbbVie, 2525 Dupont Dr., Irvine, CA, 92612, USA. anand.shewale@abbvie.com., Lateiner JE; AbbVie, 2525 Dupont Dr., Irvine, CA, 92612, USA., Dodick DW; Mayo Clinic, Phoenix, AZ, USA.
Publikováno v:
The journal of headache and pain [J Headache Pain] 2022 Apr 25; Vol. 23 (1), pp. 50. Date of Electronic Publication: 2022 Apr 25.
Publikováno v:
Hays, RD; Revicki, DA; Feeny, D; Fayers, P; Spritzer, KL; & Cella, D. (2016). Using Linear Equating to Map PROMIS (R) Global Health Items and the PROMIS-29 V2.0 Profile Measure to the Health Utilities Index Mark 3. PHARMACOECONOMICS, 34(10), 1015-1022. doi: 10.1007/s40273-016-0408-x. UCLA: Retrieved from: http://www.escholarship.org/uc/item/9rr5d786
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::66a67fd36b4c23a9f498c9fed1f6aef5
http://www.escholarship.org/uc/item/9rr5d786
http://www.escholarship.org/uc/item/9rr5d786
Autor:
Dewitt, B, Feeny, D, Fischhoff, B, Cella, D, Hays, RD, Hess, R, Pilkonis, PA, Revicki, DA, Roberts, MS, Tsevat, J, Yu, L, Hanmer, J
Publikováno v:
Dewitt, B; Feeny, D; Fischhoff, B; Cella, D; Hays, RD; Hess, R; et al.(2018). Estimation of a Preference-Based Summary Score for the Patient-Reported Outcomes Measurement Information System: The PROMIS (R)-Preference (PROPr) Scoring System. MEDICAL DECISION MAKING, 38(6), 683-698. doi: 10.1177/0272989X18776637. UCLA: Retrieved from: http://www.escholarship.org/uc/item/8c3497zd
Health-related quality of life (HRQL) preference-based scores are used to assess the health of populations and patients and for cost-effectiveness analyses. The National Institutes of Health Patient-Reported Outcomes Measurement Information System (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::757339db89e901a17a7889c7e50ae61e
http://www.escholarship.org/uc/item/8c3497zd
http://www.escholarship.org/uc/item/8c3497zd
Autor:
Derogatis LR; Maryland Center for Sexual Health, 1228 Wine Spring Lane, Towson, MD, 21204, USA. Lderogatis@MCSH.us., Revicki DA; Evidera, Bethesda, MD, USA., Rosen RC; HealthCore/New England Research Institutes, Watertown, MA, USA., Jordan R; Palatin Technologies, Inc., Cranbury, NJ, USA., Lucas J; Palatin Technologies, Inc., Cranbury, NJ, USA., Spana C; Palatin Technologies, Inc., Cranbury, NJ, USA.
Publikováno v:
Journal of patient-reported outcomes [J Patient Rep Outcomes] 2021 Sep 24; Vol. 5 (1), pp. 100. Date of Electronic Publication: 2021 Sep 24.
Autor:
Patel JL; University of Utah and ARUP Laboratories, Salt Lake City, UT, USA., Abedi M; University of California, Davis, Sacramento, CA, USA., Cogle CR; University of Florida, Gainesville, FL, USA., Erba HP; Duke University, Durham, NC, USA., Foucar K; University of New Mexico School of Medicine, Albuquerque, NM, USA., Garcia-Manero G; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grinblatt DL; NorthShore University HealthSystem, Evanston, IL, USA., Komrokji RS; H. Lee Moffitt Cancer Center, Tampa, FL, USA., Kurtin SE; University of Arizona Cancer Center, Tucson, AZ, USA., Maciejewski JP; Cleveland Clinic Foundation, Cleveland, OH, USA., Pollyea DA; University of Colorado, Aurora, CO, USA., Revicki DA; Outcomes Research Consulting, Sarasota, FL, USA., Roboz GJ; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, USA., Savona MR; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Scott BL; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Sekeres MA; Leukemia Program, Cleveland Clinic, Cleveland, OH, USA., Steensma DP; Dana-Farber Cancer Institute, Boston, MA, USA., Thompson MA; Advocate Aurora Health, Milwaukee, WI, USA., Dawn Flick E; Bristol Myers Squibb, Princeton, CA, USA., Kiselev P; Bristol Myers Squibb, Princeton, CA, USA., Louis CU; Bristol Myers Squibb, Princeton, CA, USA., Nifenecker M; Bristol Myers Squibb, Princeton, CA, USA., Swern AS; Bristol Myers Squibb, Princeton, CA, USA., George TI; University of Utah and ARUP Laboratories, Salt Lake City, UT, USA.
Publikováno v:
International journal of laboratory hematology [Int J Lab Hematol] 2021 Jun; Vol. 43 (3), pp. 426-432. Date of Electronic Publication: 2020 Nov 21.